EcoR1 Capital’s Poseida Therapeutics PSTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-676,296
Closed -$1.19M – 61
2023
Q2
$1.19M Sell
676,296
-1,973,704
-74% -$5.04M 0.03% 49
2023
Q1
$8.16M Hold
2,650,000
– – 0.26% 34
2022
Q4
$14M Hold
2,650,000
– – 0.43% 33
2022
Q3
$9.36M Buy
+2,650,000
New +$8.76M 0.28% 38

Other funds holding PSTX

EcoR1 Capital's PSTX Position: Q3 2023 in Review

EcoR1 Capital sold out of Poseida Therapeutics (PSTX) in Q3 2023, closing a stake of 676,296 shares — an estimated $1.19M sold.

EcoR1 Capital first reported a position in PSTX in Q3 2022 and held it in 4 quarters. The position peaked at $14M in Q4 2022. 86 funds tracked by Wall St. Rank hold PSTX as of Q3 2023.

  • EcoR1 Capital reported no remaining Poseida Therapeutics position as of Q3 2023 after selling out during the quarter.
  • EcoR1 Capital sold 676,296 Poseida Therapeutics shares in Q3 2023, an estimated $1.19M.
  • EcoR1 Capital first reported a position in Poseida Therapeutics in Q3 2022 and held it in 4 quarters.
  • EcoR1 Capital's Poseida Therapeutics position peaked at $14M in Q4 2022.
  • 86 funds tracked by Wall St. Rank held Poseida Therapeutics as of Q3 2023.

Based on EcoR1 Capital's 13F filing for Q3 2023, filed 14 Nov 2023.